- TV Footage
- Integrated Annual Reports
- Quarterly Reports
- Bayer Magazine
- BEENOW Magazine
- Farming’s Future Magazine
- research Magazine
- technology solutions Magazine
- From Molecules to Medicine
- From Molecules to Veterinary Medicines Brochure
- Integrated Weed Management
- Names | Figures | Facts
- Transfers of Value to Physicians Brochure
- Newsletter Overview
- Social Media
- Media Contact
Leverkusen, October 12, 2016 – Bayer was awarded second place in the latest Good Company Ranking of the DAX 30 companies. According to the organizer, Kirchhoff Consult AG, this is the biggest sustainability ranking in Germany. The assessment focused on companies’ performance in the areas of society, employees, the environment and financial integrity. Bayer was rated particularly highly in the area of society, among other reasons because of its systematic dialogue with its various stakeholders and the integration of the results of this dialogue into the company's decision-making processes. In the environment category, Bayer's activities for maintaining sustainability standards in the supply chain were assessed particularly positively.
“We are delighted by this accolade and will continue to rigorously pursue our commitment to sustainability,” said Dr. Hartmut Klusik, member of the Bayer Board of Management responsible for Human Resources, Technology and Sustainability. “Sustainability is a core element of our strategy.”
The Good Company Ranking 2016 is based on data for the 2015 fiscal year. The assessment was performed by a scientific committee under the direction of Professor Edeltraud Günther from TU Dresden University.
For more information go to www.bayer.com
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.